CORRECTED-Novartis study shows skin cancer combo also works on lungs

June 6 (Reuters) - A Novartis trial of two drugs

against an aggressive lung cancer bodes well for broadening

their use beyond melanoma, the Swiss drugmaker told the American

Society of Clinical Oncology's conference in Chicago on Monday.

Read more